Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)

18,400 -0,060 (-0,33%) In data: 01:26PM HKT. Mercato aperto.

Shanghai HeartCare Medical Technology Corporation Limited

Building 38
Floor 1 and 3 No. 356, Zhengbo Road Lingang New District, Pilot Free Trade Zone
Shanghai
China

https://www.heartcare.com.cn

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 368

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Guohui Wang	Chairman & CEO	1,28M	N/D	1979
Ms. Kun Zhang	Deputy GM & Executive Director	1,17M	N/D	1979
Mr. Jiawei Wei	Deputy GM & Executive Director	1,15M	N/D	1979
Mr. Han Zhang	CFO & Joint Company Secretary	N/D	N/D	1988
Mr. Zongyu Xue	VP of Quality Regulation & Employee Representative Supervisor	N/D	N/D	1985
Ms. Siu Ying Kwok	Joint Company Secretary	N/D	N/D	1985

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in HKD.

Descrizione

Shanghai HeartCare Medical Technology Corporation Limited researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China. The company offers ischemic stroke thrombectomy devices, such as Captor thrombectomy device, and aspiration catheter and pump; intracranial stenosis treatment devices comprising intracranial drug-eluting balloon catheter and embolization protection system; hemorrhagic stroke treatment devices, including coil embolization assistant stent and flow diverter device; and ischemic stroke prevention devices, such as LAA occlude. It also provides vascular access devices comprising distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter. The company's products are used for acute ischemic stroke and neurovascular stenosis treatment, hemorrhagic stroke treatment, ischemic stroke prevention, and interventional access. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.

Governance aziendale

L'ISS Governance QualityScore di Shanghai HeartCare Medical Technology Corporation Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.